Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate
2006-06-23
2009-02-17
Mosher, Mary E (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
C424S204100, C435S235100, C435S236000
Reexamination Certificate
active
07491399
ABSTRACT:
The present invention relates to a non pathogenic vaccine comprising a recombinant Infectious Bursal Disease virus that includes a recombinant Segment A, designated as rD78GLSNSΔ, that includes sequences from D78 and GLS strains and wherein the NS protein is not expressed.
REFERENCES:
patent: 6231868 (2001-05-01), Vakharia et al.
patent: 6451321 (2002-09-01), Mundt et al.
patent: 6485940 (2002-11-01), Mundt et al.
patent: 7022327 (2006-04-01), Lutticken et al.
patent: 2005/0176128 (2005-08-01), Thies
patent: 2006/0251663 (2006-11-01), Mariscal-Gonzalez et al.
patent: 9526196 (1995-10-01), None
Mundt et al., “Vp5 of Infectious Bursal Disease Virus is not Essential for Viral Replication in Cell Culture,” Journal of Virology, vol. 71, No. 7 (1997), pp. 5647-5651.
Yao et al., “Generation of a Mutant Infectious Bursal Disease Virus That Does Not Cause Burdal Lesions,” Journal of Virology, vol. 72, No. 4 (1998), pp. 2647-2654.
Rautenschlein et al. Differences in the immunopathogenesis of infectious bursal disease virus (IBDV) following in ovo and post-hatch vaccination of chickens. Veterinary Immunology and Immunopathology 106 (2005) 139-150.
Giambrone et al (Avian Diseases 45:144-148, 2001).
Coletti et al (Avian Diseases 45:1036-1043, 2001).
Azad, A. A., et al., “The characterization and molecular cloning of the double-stranded RNA genome of an Australian strain of infectious...”, “Virology”, 1985, pp. 35-44, vol. 143.
Dobos, Peter, “Peptide map comparison of the proteins of infectious bursal disease virus”, “Journal of Virology”, Dec. 1979, pp. 1046-1050, vol. 32, No. 3.
Giambrone, J. J. et al., “Safety and efficacy of in ovo administration of infectious bursal disease viral vaccines”, “Avian Diseases”, 2001, pp. 144-148, vol. 45.
Hudson, Peter J., et al., “Genomic structure of the large RNA segment of infectious bursal disease virus”, “Nucleic Acids Research”, 1986, pp. 5001-5012, vol. 14, No. 12.
Kibenge, F. S. B., et al., “Biochemistry and immunology of infectious bursal disease virus”, “J. Gen. Virol.”, 1988, pp. 1757-1775, vol. 69.
Lutticken, D., et al., “Determination of the breakthrough titre of IBD vaccines or IBD challenge strains in MDA chickens”, “Proceedings of the International Symposium on Infectious Bursal Disease and Chicken Infectiuos Anaemia”, 1994, pp. 224-279, Published in: Rauischholzhausen, Germany.
Masteller, Emma L., et al., “B cell development in the chicken”, “Poultry Science”, 1994, pp. 998-1011, vol. 73.
Mundt, Egbert, et al., “Synthetic transcripts of double-stranded Bimavirus genome are infectious”, “Proc. Natl. Acad. Sci. USA”, Oct. 1, 1996, pp. 11131-11136, vol. 93, No. 20.
Mundt, Egbert, et al., “Development of a vaccine for immunization against classical as well as variant strains of infectious bursal disease...”, “Vaccine”, 2003, pp. 4616-4624, vol. 21.
Nunoya, T., et al., “Occurrence of acute infectious bursal disease with high mortality in Japan and Pathogenicity of field isolates in ...”, “Avian Diseases”, 1992, pp. 597-609, vol. 36.
Sharma, J. M., “Embryo vaccination of chickens with turkey herpesvirus: characteristics of the target cell of early viral replication...”, “Avian Pathology”, 1987, pp.567-579, vol.16.
Snyder, D. B., et al., “Naturally occuring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal...”, “Arch. Virol,”, 1992, pp. 89-101, vol. 127.
Snyder, D. B., et al., “Active cross-protection induced by a recombinant baculovirus expressing chimeric infectious bursal disease virus...”, “Avian Diseases”, 1994, pp. 701-707, vol. 38.
Vakharia, Vikram N., et al., “Molecular basis of antigenic variation in infectious bursal disease virus”, “Virus Res.”, Feb. 1994, pp. 265-273, vol 31, No. 2.
Vakharia, Vikram N., “Development of recombinant vaccines against infectious bursal disease”, “Biotechnology Annual Review”, 1997, pp. 151-168, vol. 3.
Van Den Berg, T. P., et al., “Acute infectious bursal disease in poultry: isolation and characterization of highly virulent strain”, “Avian Pathology”, 1991, pp. 133-143, vol. 20.
Liu, Meihong, “Pathogenesis and Apoptosis Study of Infectious Bursal Disease Virus (IBDV) and Development of a Bivalent Recombinant IBD”, Phd Dissertation of Meihong Liu, 2003, Publisher: University of Maryland pp. 67-145 only,
Hultquist Steven J.
Intellectual Property / Technology Law
Mosher Mary E
Reynolds Kelly K.
University of Maryland Biotechnology Institute
LandOfFree
In Ovo vaccine against infectious bursal disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with In Ovo vaccine against infectious bursal disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In Ovo vaccine against infectious bursal disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4061368